Related Experiment Video
Updated: Jul 1, 2026
08:23
Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
Published on: February 16, 2022
Nitric oxide and cardiovascular and renal effects
1Nephrology/Hypertension Division, University of Miami, Veterans Affairs Medical Center, Miami, FL, USA. lraij@med.miami.edu
Osteoarthritis and Cartilage
|October 1, 2008
Summary
Nitric oxide (NO) protects cardiovascular and renal systems, but its effects are opposed by angiotensin-II (Ang II). Balancing NO and Ang II is key for cardiovascular health and developing new therapies.
Area of Science:
- Cardiovascular Physiology
- Renal Physiology
- Pharmacology
Background:
- Nitric oxide (NO) exerts protective effects on cardiovascular and renal systems.
- Key NO functions include vasodilation, anti-inflammation, and anti-thrombosis.
- Angiotensin-II (Ang II) antagonizes many NO-mediated activities.
Purpose of the Study:
- To review the interplay between NO and Ang II in cardiovascular and renal regulation.
- To highlight the significance of the NO/Ang II balance in health and disease.
- To explore therapeutic strategies targeting NO modulation for cardiovascular conditions.
Main Methods:
- Literature review of studies investigating NO and Ang II interactions.
- Analysis of physiological and pathophysiological roles of NO and Ang II.
- Examination of therapeutic applications of NO donors.
Main Results:
- The balance between NO and Ang II, not their individual concentrations, dictates physiological and pathophysiological outcomes.
- Dysregulation of this balance contributes to cardiovascular and renal diseases.
- NO donors are established treatments for conditions like angina and myocardial infarction.
Conclusions:
- Understanding the NO-Ang II axis is crucial for cardiovascular and renal health.
- Therapeutic interventions should aim to restore the balance between NO and Ang II.
- Further research into NO-modulating therapies holds promise for novel treatments.
Related Concept Videos
01:28Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:16Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...